Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Khiron Life Sciences Corp. (V:KHRN)

Business Focus: Alternative Medicine

INK Edge Outlook

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for KHRN within the last 6 months
See all filings within the past 6 months

Company News

Oct 07, 2021 07:00 ET
Khiron Life Sciences Corp.: Invitation to the Benzinga Cannabis Capital Conference
Toronto, Ontario--(Newsfile Corp. - October 7, 2021) - Khiron Life Sciences Corp. (TSXV: KHRN.V) (OTCQX: KHRNF) (FSE: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, will be participating in the Benzinga Cannabis Capital Conference, which will take place on October 14 and October 15 at the Marriott Marquis hotel in New York City.
Read full article
Oct 07, 2021 06:00 ET
Khiron presents its first research study with 1,400 patients
12-month observational study results presented at the International Pain Conference in Colombia on September 25th, 2021
Read full article
See more news stories

Valuation Ratios

Price to Sales - TTM
Price to Book - most recent quarter
Price to Cash Flow per share - TTM
Price to Free Cash Flow per share - TTM
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Oct 15, 2021228,518-171,941
Sep 30, 2021400,459318,586
Sep 15, 202181,873-21,401
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

Khiron Life Sciences Corp, formerly Adent Capital Corp, is a Canada-based company engaged in alternative medicine sector. The Company is an integrated medical cannabis company with its core operations in Latin America. Khiron is active in the research area in medical cannabis industry. It develops and commercializes medical cannabis products mainly in Colombia.

See business summary



Search (past week) for $KHRN.CA KHRN.V

  • No tweets found